Ultimovacs ASA Stock Forecast - Accumulation Distribution
ULTI Stock | NOK 1.98 0.05 2.46% |
Ultimovacs Stock Forecast is based on your current time horizon.
Ultimovacs |
Previous Accumulation Distribution | Accumulation Distribution | Trend |
32804.36 | 72029.55 |
Check Ultimovacs ASA Volatility | Backtest Ultimovacs ASA | Trend Details |
Ultimovacs ASA Trading Date Momentum
On October 17 2024 Ultimovacs ASA was traded for 1.79 at the closing time. The highest price during the trading period was 1.82 and the lowest recorded bid was listed for 1.75 . The volume for the day was 335.1 K. This history from October 17, 2024 contributed to the next trading day price upswing. The trading price change to the next closing price was 0.56% . The trading price change to the current price is 1.12% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Ultimovacs ASA to competition |
Other Forecasting Options for Ultimovacs ASA
For every potential investor in Ultimovacs, whether a beginner or expert, Ultimovacs ASA's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ultimovacs Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ultimovacs. Basic forecasting techniques help filter out the noise by identifying Ultimovacs ASA's price trends.Ultimovacs ASA Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ultimovacs ASA stock to make a market-neutral strategy. Peer analysis of Ultimovacs ASA could also be used in its relative valuation, which is a method of valuing Ultimovacs ASA by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Ultimovacs ASA Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ultimovacs ASA's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ultimovacs ASA's current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Ultimovacs ASA Market Strength Events
Market strength indicators help investors to evaluate how Ultimovacs ASA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ultimovacs ASA shares will generate the highest return on investment. By undertsting and applying Ultimovacs ASA stock market strength indicators, traders can identify Ultimovacs ASA entry and exit signals to maximize returns.
Ultimovacs ASA Risk Indicators
The analysis of Ultimovacs ASA's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ultimovacs ASA's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ultimovacs stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.64 | |||
Standard Deviation | 6.61 | |||
Variance | 43.73 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Ultimovacs Stock
Ultimovacs ASA financial ratios help investors to determine whether Ultimovacs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ultimovacs with respect to the benefits of owning Ultimovacs ASA security.